Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Nathaniel L Anderson v. Peregrine Pharmaceuticals Inc et al
Case Number:
8:12-cv-01647
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
-
May 05, 2014
Peregrine Again Escapes Investor Suit Over Lung Cancer Drug
A California federal judge dismissed a consolidated class action against Peregrine Pharmaceuticals Inc. for the second time on Friday, saying the suit had failed to adequately allege that the drugmaker acted recklessly by knowingly lying about its lung cancer drug.
-
August 26, 2013
Peregrine Beats Shareholder Suit Over Lung Cancer Drug
A California federal judge tossed a consolidated class action against Peregrine Pharmaceuticals Inc. on Friday, saying the investor plaintiffs didn't adequately allege that the drugmaker and its executives knowingly lied about its lung cancer drug, causing a nosedive of the company's stock price.
-
October 30, 2012
Peregrine Sued By Investors Over Cancer Drug Claims
Investors hit Peregrine Pharmaceuticals Inc. with multiple securities class actions last month, alleging that the drugmaker's misleading statements about its lung cancer drug later resulted in a nosedive of the company's stock price.